Literature DB >> 16849638

FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis.

Gestur Vidarsson1, Annette M Stemerding, Nigel M Stapleton, Suzanne E Spliethoff, Hans Janssen, Frank E Rebers, Masja de Haas, Jan G van de Winkel.   

Abstract

Here, we report that the MHC class I-related neonatal Fc receptor (FcRn) is expressed within azurophilic and specific granules of neutrophils and relocates to phagolysosomes on phagocytosis of IgG-opsonized bacteria. We found FcRn to enhance phagocytosis in a pH-dependent manner which was independent of IgG recycling. IgG-opsonized bacteria were inefficiently phagocytosed by neutrophils from beta2M knock-out or FcRn alpha-chain knock-out mice, which both lack expression of FcRn. Similarly, low phagocytic activity was also observed with mutated IgG (H435A), which is incapable of binding to FcRn, while retaining normal binding to classical leukocyte Fcgamma receptors. Finally, a TAT peptide representing intracellular endocytosis and transport motifs within FcRn strongly inhibited IgG-mediated phagocytosis. These findings support a novel concept in which FcRn fulfills a major role in IgG-mediated phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849638     DOI: 10.1182/blood-2006-05-024539

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  70 in total

Review 1.  Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.

Authors:  Imre Kacskovics; Judit Cervenak; Anna Erdei; Richard A Goldsby; John E Butler
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

2.  Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.

Authors:  Algirdas Grevys; Malin Bern; Stian Foss; Diane Bryant Bratlie; Anders Moen; Kristin Støen Gunnarsen; Audun Aase; Terje Einar Michaelsen; Inger Sandlie; Jan Terje Andersen
Journal:  J Immunol       Date:  2015-04-22       Impact factor: 5.422

Review 3.  FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.

Authors:  Michal Pyzik; Timo Rath; Wayne I Lencer; Kristi Baker; Richard S Blumberg
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

4.  Dependence of antibody-mediated presentation of antigen on FcRn.

Authors:  Shuo-Wang Qiao; Kanna Kobayashi; Finn-Eirik Johansen; Ludvig M Sollid; Jan Terje Andersen; Edgar Milford; Derry C Roopenian; Wayne I Lencer; Richard S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-01       Impact factor: 11.205

Review 5.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 6.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

Review 7.  Targeting FcRn for the modulation of antibody dynamics.

Authors:  E Sally Ward; Siva Charan Devanaboyina; Raimund J Ober
Journal:  Mol Immunol       Date:  2015-03-09       Impact factor: 4.407

8.  Activation of the JAK/STAT-1 signaling pathway by IFN-gamma can down-regulate functional expression of the MHC class I-related neonatal Fc receptor for IgG.

Authors:  Xindong Liu; Lilin Ye; Yu Bai; Habi Mojidi; Neil E Simister; Xiaoping Zhu
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Beta2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia.

Authors:  Anna L Cogen; Thomas A Moore
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

10.  Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice.

Authors:  Héctor Pérez Montoyo; Carlos Vaccaro; Martin Hafner; Raimund J Ober; Werner Mueller; E Sally Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.